Oncology Reports · 2019 · 21 citations · 28 references
PharmacyOncologyPharmacologyCancer PharmacologyDrug DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineMetastatic Disease TreatmentNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineCancer NanotherapyCell Growth MonitoringCell Growth RegulationDrug-induced ApoptosisIron Oxide NanoparticlesOsteosarcoma TreatmentRiluzole TherapyRiluzole Treatment
Osteosarcomas are the most commonly occurring malignant bone cancer in young individuals. The survival rate of patients with metastatic osteosarcoma is low and has been stagnant for over two decades. We previously demonstrated that the glutamate release inhibitor, riluzole inhibits osteosarcoma cell growth. Towards the development of more effective therapy, we investigated the delivery of riluzole in human metastatic osteosarcoma xenografts in mice. We compared the efficacy of riluzole delivery by intraperitoneally injecting either free riluzole or riluzole released via two different shapes of iron oxide nanoparticles (nanocage or nanosphere) of size 15±2.5 nm. We monitored tumor size using Vernier calipers and bioluminescence assay and found a significant reduction in tumor size in the riluzole‑treated groups when injected, either in free form or via nanoparticles, compared to the control groups (PBS, nanosphere or nanocage). Importantly, nanocage‑delivered riluzole was most effective in reducing tumor size in the xenograft nude mice. While riluzole delivery induced apoptosis in tumor tissues in all three groups of riluzole‑treated animals, it was highest in tumors from the nanocage‑delivered riluzole group. Therefore, we conclude that riluzole is an effective drug to reduce tumor size in osteosarcoma and the efficacy of riluzole as a apoptotic and tumor‑reducing drug is enhanced when delivered via nanocage.
28
Osteosarcoma incidence and survival rates from 1973 to 2004
Rebecca Troisi, Sharon A. Savage · Cancer · 2009 · 2.2K citations · Full text
Investigating the Impact of Nanoparticle Size on Active and Passive Tumor Targeting Efficiency
Edward A. Sykes, Juan Chen, Gang Zheng et al. · ACS Nano · 2014 · 626 citations
Pharmacy, Oncology, Pharmaceutics +17
Galvanic Replacement Reactions in Metal Oxide Nanocrystals
Myoung Hwan Oh, Taekyung Yu, Seung‐Ho Yu et al. · Science · 2013 · 541 citations
Metastatic osteosarcoma at diagnosis
Valérie Mialou, Thierry Philip, C Kalifa et al. · Cancer · 2005 · 291 citations